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Abstract
Background. Structural MRI measures for monitoring Alzheimer’s
Disease (AD) progression are becoming instrumental in the clinical prac-
tice, and more so in the context of longitudinal studies. This investigation
addresses the impact of four image analysis approaches on the longitudinal
performance of the hippocampal volume.
Methods. We present an hippocampal segmentation algorithm and
validate it on a gold-standard manual tracing database. We segmented 460
subjects from ADNI, each subject having been scanned twice at baseline, 12-
month and 24 month follow-up scan (1.5T, T1 MRI). We used the bilateral
hippocampal volume v and its variation, measured as the annualized volume
change Λ = δv/year (mm3/y). Four processing approaches with different
complexity are compared to maximize the longitudinal information, and they
are tested for cohort discrimination ability. Reference cohorts are Controls vs.
Alzheimer’s Disease (CTRL/AD) and CTRL vs. Mild Cognitive Impairment
who subsequently progressed to AD dementia (CTRL/MCI-co). We discuss
the conditions on v and the added value of Λ in discriminating subjects.
Results. The age-corrected bilateral annualized atrophy rate (%/year)
were: -1.6 (0.6) for CTRL, -2.2 (1.0) for MCI-nc, -3.2(1.2) for MCI-co and
-4.0 (1.5) for AD. Combined (v,Λ) discrimination ability gave a Area under
the ROC curve (auc) = 0.93 for CTRL vs AD and auc = 0.88 for CTRL vs
MCI-co.
Conclusions. Longitudinal volume measurements can provide mean-
ingful clinical insight and added value with respect to the baseline provided
the analysis procedure embeds the longitudinal information.
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Abbreviations:
AD, Alzheimer’s Disease
ADNI, Alzheimer’s disease Neuroimaging Initiative;
AUC, Area Under Curve;
CTRL, Control Subjects;
MCI(-nc/-co), Mild Cognitive Impairment (non-progressing to AD / pro-
gressing to AD);
MNI, Montreal Neurological Institute;
MRI, Magnetic Resonance Imaging.
ROC, Receiver Operating Characteristic.
SVM, Support Vector Machine;
VOI, Volume Of Interest;
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1. Introduction1
Among image-based markers, structural information is considered highly2
informative in the quantification of progression to Alzheimer’s disease (AD).3
This is becoming even more important in the context of longitudinal stud-4
ies where substantial literature (Hogan et al., 2004; Bateman et al., 2012;5
McEvoy et al., 2011; Spulber et al., 2013; Lobanova et al., 2014; Leung et al.,6
2010; Schuff et al., 2009; Rusinek et al., 2003; Fox and Schott, 2004) suggests7
that longitudinal trend may be pivotal in discriminating a population at risk.8
In addition, there is enough scientific evidence supporting the use of the9
hippocampal geometrical properties (such as the hippocampal volume) as10
biomarker of early / progression of AD, and the reader is referred to Franko´11
and Joly, Olivier (2013); Chincarini et al. (2011); Gerardin et al. (2009);12
Fennema-Notestine et al. (2009) for a sample of studies in the field.13
There are now a number of methods to automatically segment the hip-14
pocampal structure, many of them featuring high accuracy and reliability15
(Shen et al., 2002; Morra et al., 2008; Pruessner et al., 2000; Bishop et al.,16
2011; Wolz et al., 2010b, 2014). In addition, the recently concluded seg-17
mentation harmonization effort (see Frisoni et al. (2014); Apostolova et al.18
(2015)) delivered a set of gold-standard tracings to be used as reference for19
both human and automatic readers (Bocchetta et al., 2014; Boccardi et al.,20
2015).21
Despite the use of gold-standard segmentations, the reliability and the22
clinical usefulness of a longitudinal measurement can be hindered by several23
confounding factors, namely: technical errors (acquisition noises, artefacts,24
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data analysis and algorithmic instabilities) and physiological variability (both25
intrinsic and due to external conditions such as hydration, lipidic balance,26
nutrition and hormonal concentration, Duning et al. (2005); Maclaren et al.27
(2014)). The goal of longitudinal analysis though is to find the long-term28
trend due to either normal or pathological ageing, neglecting the nuisances29
of both intrinsic and extrinsic variabilities.30
Our investigation here looks for possible implementations of a segmenta-31
tion-based longitudinal marker, aiming at the reduction of variabilities other32
than the long-term aging contribution. First, we develop a segmentation al-33
gorithm on a separate dataset, delivering the hippocampal volume. Then,34
we segment a large number of MR images from ADNI and use the hippocam-35
pal volume to construct a longitudinal marker. This marker is implemented36
with four algorithmic variations of increasing complexity, meant to enhance37
the robustness and accuracy of the segmentation over the longitudinal scans.38
Finally, we assess the marker prognostic potential and estimate under which39
conditions the longitudinal information is clinically relevant.40
2. Materials and methods41
2.1. Dataset42
MRI scans (1.5T, T1-weighted) were selected from the ADNI database 243
and downloaded in the original format (DICOM). The subjects id list is44
provided in supplemental table S1.45
2The ADNI was launched in 2003 by the National Institute on Aging (NIA), the Na-
tional Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug
Administration (FDA), private pharmaceutical companies and non-profit organizations.
For up-to-date information, see www.adni-info.org.
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We selected 460 subjects having four scans: two scans at baseline (here-46
after labelled baseline and repeat), 12-month and 24-month scans for a total47
of 460× 4 = 1840 images.48
According to the ADNI evaluators, subjects were grouped in three cohorts49
consisting of 148 Controls (CTRL), 216 Mild Cognitive Impairment (MCI)50
and 96 Alzheimer’s Disease (AD) (clinical label given at baseline). Coarse51
statistical description is summarized in table 1.52
MCI subjects were further divided into 121 “MCI progressing to AD”53
(MCI-co) and 95 stable MCI, or“MCI non-progressing” (MCI-nc) according54
to the clinical follow-up which stretched up to 96 months after the baseline55
scan. A few MCI subjects (8) received more than two labels during follow-up56
(MCI / AD / normal cognition). They were treated considering the first and57
the latest evaluation only.58
On average, time to AD occurred after 48 (24 – 84) months (90% confi-59
dence bounds) from the baseline.60
2.2. Image processing61
Image processing closely follows the method detailed in Chincarini et al.62
(2011), save for two procedural differences. We summarize here the main63
steps applied to each MR image up to the extraction of its Volumes of Interest64
(VOI), which were used as starting points of the segmentation algorithm.65
MR images underwent a series of filters designed for bias B-field reduc-66
tion, volume normalization, anatomical structure registration and gray level67
intensity equalization. The two novelties with respect to Chincarini et al.68
(2011) are the lack of the pyramidal noise filter and the addition of the B-69
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field bias reduction, the latter implemented with the BET algorithm (Smith,70
2002). The noise filtering step was avoided to keep the intensity contrast71
between the hippocampus structure and the adjacent structures (amigdala72
mainly), which could be impaired by the pyramidal filter. Similarly, the B-73
field bias correction was introduced to improve on the deformable registration74
cost function used in the segmentation process.75
As result of the pre-processing steps, images were aligned with a 12-pa-76
rameters affine transformation to the Montreal Neurological Institute (MNI,77
mazziotta, Toga, Evans, Fox (1995)) space and the mean gray level intensi-78
ties of the three major brain constituents - cerebro-spinal fluid (CSF), gray79
matter (GM) and white matter (WM) - were matched to reference values.80
In addition, aligned images are spatially sampled as the MNI template, that81
is with isotropic voxels of 1mm.82
Each image was then sampled with 2 VOIs with dimension 30×80×40 mm83
each, which were placed in both Medial Temporal Lobes (MTL) so that the84
hippocampi are anatomically aligned to the VOIs sagittal axes (see figure 185
for an example of VOI positioning and content).86
Finally, a finer intra-cranial volume correction (icv) is computed by non-87
linear mapping of the segmented MNI brain mask (provided with the tem-88
plate) onto the affine-registered image and the mask volume is weighted by89
the affine transformation jacobian. This number is a minor factor (of the90
order of the unity) and it does not correct for the native volume versus the91
MNI-space one, as the spatial normalization already compensated for it. It92
is rather used to adjust for the possible deviations that escape the affine reg-93
istration. This non-linear-based intra-cranial volume adjustment is used as94
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a hippocampal volume correction factor after the segmentation process.95
2.3. Segmentation algorithm96
The main ground for developing our own segmentation procedure instead97
of using an existing one was the choice to have it under control and to use a98
probabilistic atlas approach rather than voxel-based classification techniques.99
The procedure (referred in the following as GDIseg) requires only the100
hippocampal VOI in input and it is not too dissimilar from that proposed101
by Wolz et al. (2010a), save for some details. It was developed on a MR102
set consisting of 100 T1-weighted MR images and tracings (Frisoni et al.103
(2014), preliminary release) from the “harmonized protocol for hippocampal104
volumetry” project (HarP, www.hippocampal-protocol.net), subjects not105
included in the dataset presented in this investigation.106
For the purpose of this investigation we require only two outputs from107
GDIseg : the bilateral hippocampal volume v and a spatial probability map108
A, which should ideally peak on the hippocampi voxels and quickly fade to109
zero on all other brain structures. The GDIseg algorithm is described in110
Appendix A.111
2.4. Implementations112
We implemented the longitudinal analysis procedure with four progressive113
steps, starting with a naive approach in which all scans are treated separately,114
to a fully integrated one in which image processing and segmentation are115
intertwined. A schematic comparison of the four implementations is given in116
figure 2.117
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All descriptions regarding the hippocampal VOIs have no explicit later-118
ality labels but it is intended that they are run on the left and right VOI119
separately.120
2.4.1. A: independent processing and segmentation121
Each scan is treated independently. The icv correction is also computed122
separately on the four scans; no longitudinal (i.e. time) information is used123
(figure 2 A). This implementation serves as base comparison to assess the124
performance increase of more sophisticated approaches.125
2.4.2. B: unified image processing126
In this implementation image preprocessing is merged by generating an127
unbiased within-subject template space, while segmentation follows on each128
VOI independently (figure 2 B).129
The within-subject template is constructed by generating an average in-130
termediate image H from the 4 scans (baseline, repeat, month 12 and month131
24) using robust, inverse consistent registration (Reuter et al., 2012). The132
intermediate within-subject template is processed up to the extraction of133
the hippocampal VOIs according to section 2.2. The relevant parameters134
(registration onto the MNI reference, VOI positions and intensity normaliza-135
tion) are passed back to the original scans so that the actual VOIs can be136
extracted.137
This implementation ensures that all 4 scans are treated uniformly and138
the VOIs are extracted with a very high degree of reproducibility. The icv139
correction is computed on H only.140
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2.4.3. C: atlas matrix re-normalization141
This implementation shares the same image processing as in “B” but142
it adds a refinement to the segmentation algorithm (figure 2 C). This is143
based on the construction of a single deformation field f ∗ that summons the144
main longitudinal variation of the hippocampal shape. Implementation “C”145
supplements the GDIseg algorithm by adding the temporal information in146
the form of a post-processed probabilistic map A.147
Consider the four scans of a single subject and let bi be the hippocampal148
VOI extracted from scan i and Ai the related probabilistic atlas. Let also fij149
be a deformation field that maps bi onto bj (i, j = 1..4).150
We can define the 4 × 4 matrix f whose elements are the fij and which151
contains the identity transformation I on the diagonal, with the requirement152
that fij + fji = I. Similarly, we can define a matrix a of probabilistic maps153
whose elements are aij = fij(Ai), i.e. the application of the field fij to Ai.154
By definition, the diagonal elements are aii = Ai. Addition, subtraction and155
multiplication by a constant on the deformation field f are intended to be156
applied voxel-by-voxel to the displacement vector components. The identity157
operator I components are by definition all zero.158
We now assume that the main contribution to the longitudinal trend can159
be captured by a linear map of a new operator f ∗. The intent of f ∗ is160
to capture the mean, long term drift by averaging over the paths from the161
baseline to the last follow-up scan, so that162
fij ' αijf ∗, αij ∈ [0, 1]
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A possible choice for αij could be163
αij =
tj − ti
maxi,j=1..4 [tj − ti]
where ti is the time of the i
th scan. In order to find f ∗ we average the164
deformation fields on all paths connecting the earliest to the latest scan.165
The generalized expression is166
f ∗ =
1
1 + n1 + n2 + ...
(
fxy +
∑
x<k<y
(fxk + fky) +
∑
x<k<h<y
(fxk + fkh + fhy) + ...
)
where nr are the number of possible paths from x to y using r intermediates.167
The simplified expression for 4 scans (taking into account that t2 = t1) is168
f ∗ =
1
4
(f14 + f24 + (f13 + f34) + (f23 + f34))
We can now compute the new matrix f with elements αijf
∗, and hence the169
new atlas matrix a.170
We have re-normalized the probabilistic maps aij to comply with a single171
deformation field that links the VOIs extracted from the longitudinal scans.172
The re-normalized aij are averaged over the columns and then thresholded,173
to get the binary masks. Then, we apply the icv correction the same way as174
in implementation “B”.175
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2.4.4. D: weighted integration176
In this last implementation images are preprocessed as in “B” and seg-177
mentation undergoes a post-processing step, this time though we drop the178
requirement of an actual binary mask per VOI, in favour of the volume in-179
formation alone (figure 2 D).180
For each subject and bilateral VOI we define two new maps:181
Ap =
∏
j=1..4
Aj
182
Am = max
j
Aj
where j is the index to the baseline, repeat, 12 month and 24 month scans;183
the ‘max’ is taken voxel-wise over the four Aj. If x represents the gray184
intensity in any voxel, the quantity:185
W (k, y) =
∑
x∈VOIk
x Ay
is the weighted sum of the intensity values over the volume VOIk. We now186
define the longitudinal volumes as:187
vj = vˆ
W (j,m) W (1, p)
W (1,m) W (j, p)
The normalization constants vˆ is the mean volume over the baseline and188
repeat scans, as given by GDIseg.189
In short, this formulation modulates the intensities in the bigger map190
(Am, which includes the hippocampal boundary) with the inner intensity191
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values (Ap, where all segmentations agree).192
2.5. Performance metrics193
We checked the performance of all described procedures with four metrics.194
The first one (reliability) is simply a quality control to assess the robustness195
of GDIseg on a large number of images. Then we looked at the test/re-196
test performance (reproducibility) and at the longitudinal trend. Finally we197
checked whether the longitudinal information can improve on the accuracy198
when used as combined biomarker together with the volume.199
2.5.1. Reliability200
The segmentation procedure was applied without human intervention to201
1840 images from the ADNI database. A quality control test checks whether202
and on how many images the procedure crudely fails. This control does203
not imply a “correct” hippocampus segmentation - in terms of harmonized204
protocol - it only points out possible failures in the pre-processing and in205
the segmentation procedure. To perform this test we construct two identical206
statistics Revoi and Remask:207
Revoi = min
t,L,R
{max
i
[r(V OI, TBi)]}
208
Remask = min
t,L,R
{max
j
[r(mask, TMj)]}
where r is the Pearson correlation coefficient, the ‘max’ is taken on the tem-209
plates and the ‘min’ is taken among scans (t) and laterality (L,R). Template210
Boxes (TB) and Template Masks (TM) are the hippocampal VOIs and man-211
ual tracings on the HarP image dataset (see Appendix A).212
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This test computes the best correlation coefficient among the VOI inten-213
sities and each TB, as well as among the segmented mask and each TM ,214
then keeping the lowest among these values with respect to the number of215
scans and laterality. In other words, from each subject we get 8 VOIs and216
8 hippocampal tracings (bilateral regions on 4 scans). If either one or more217
are too distant from its nearest template (in terms of correlation coefficient),218
the subject is flagged for visual inspection. This formulation assumes that219
the HarP subjects are sampled as to represent all relevant physiological vari-220
ability.221
Mishaps in image processing (intensity normalization for instance), in the222
VOI extraction (registration) and in the segmentation algorithm will result in223
either one or both statistics to be significantly impaired. Visual inspection of224
outliers and most extreme values follows, to understand the reasons of failure225
and ensure that outliers are indeed the only images on which the automatic226
procedure failed. Subjects failing this test are discarded.227
2.5.2. Reproducibility228
We addressed the statistics of the segmentation volumetry comparing229
baseline and repeat scans. This tests is crucial for informed use in both230
research and clinical settings. Test/re-test reproducibility - i.e. how the231
outcome measure varies when computed over two repeat scans acquired in232
the absence of plausible biological variability - is a critical measure for reliable233
biomarkers. The considered quantity is234
∆ = 2
vr − vb
vr + vb
=
vr − vb
vˆ
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where vb and vr are the baseline and repeat hippocampal volumes respec-235
tively.236
2.5.3. Longitudinal trend237
The annualized volume change Λ (expressed in mm3/year) is defined as238
the slope of the least-squares linear fit of the longitudinal volume measures239
vi versus time:240
vi − ξi = Λ ti + β
where ξi and β are the residuals and the intercept respectively, and i = 1..4241
tags the baseline, repeat, 12-month and 24-month scans. To make Λ more242
robust we did not choose to split measures into 0-12m and 12m-24m intervals243
as in Schuff et al. (2009).244
A linear model using age, sex and cohort as predictors found cohort and245
age as significant (p < 10−4). We adjusted Λ for age using de-correlation.246
Then, we used de-correlation to cross-check whether Λ maintains signifi-247
cant prognostic performance after the adjustment for vˆ and mini-mental state248
examination (MMSE) score.249
2.5.4. Combined markers250
The added complexity to derive a longitudinal biomarker – albeit a simple251
one based on the hippocampal volume drift over time – should be balanced252
by an increased prognostic potential.253
ROC analysis on the combined volume and trend indexes was computed254
with a linear discriminant. We used a support vector machine (SVM) classi-255
fier on the feature set (vˆ,Λ) and we considered the distance from the sepa-256
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rating plane as the new marker. Its performance was compared to that of vˆ257
and Λ alone.258
2.6. Software and statistics259
Image processing was carried out on a dedicated computational farm260
running the LONI pipeline software (www.loni.ucla.edu), using MATLAB261
(www.mathworks.com) and ITK (www.itk.org) as algorithm libraries. All262
statistical analyses were carried out within the MATLAB environment.263
The Λ score was adjusted for specific variables by de-correlation using264
linear regression in the following manner:265
Λadji = Λi −
(
βˆ0 +
∑
j
βˆjxij
)
where Λi is the score from the ith subject, xij is variable j of subject i to be266
adjusted for, and βˆi is estimated using a least squares fit Λi = β
0 +
∑
j βjxij267
to the considered dataset. We adjusted for either age or for MMSE, as268
they are among the major confounders and we checked whether Λadj still269
carried information. No dominant non-linear relationships were observed270
when inspected by scatter plots. Consequently, a linear adjustment was271
considered sufficient.272
A SVM classifier with linear kernel was trained on CTRL vs. MCI-273
co cohorts. The trained classifier was used to assess the AD and MCI-nc274
cohorts. The combined marker was the distance from the SVM separating275
plane. ROC analysis of the combine marker (vˆ,Λ) on CTRL vs. MCI-co are276
given with a 20-fold cross-validation method. Right and left structures were277
treated separately.278
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Confidence intervals on AUC values in table 3 were computed by boot-279
strapping (1000 times) and by using the bias-corrected percentile method280
(Martinez, 2011). Statistical significance in table 4 versus the null AUC and281
among different markers was carried on according to Hanley and McNeil282
(1982, 1983).283
The estimation of confidence intervals on the AUC can be carried out with284
several methods, each delivering slightly different values. Hence the compari-285
son and compatibility among tests in table 3 and 4 should take into consider-286
ation that confidence intervals are method-dependent estimates. We consid-287
ered seven methods, parametric and non-parametric: Hanley-McNeil (para-288
metric); Mann-Whitney, Logit and Bootstrap (non-parametric, Gengsheng289
Qin and Hotilovac (2007)); Maximum variance (non-parametric, Cortes and290
Mohri (2004)); Wald, Wald/continuity-corrected (non-parametric, Kottas291
et al. (2014)).292
For instance, the width of the confidence interval on vˆL for the CTRL/AD293
cohorts (implementation D, AUC=0.89 in table 3) ranges from 0.06 (Hanley-294
McNeil) to 0.09 (Mann-Whitney); in numbers 0.86−0.92 and 0.84−0.93. An-295
other example with ΛR, implementation C and CTRL/MCI-co (AUC=0.78)296
shows a substantially similar interval width of all methods (0.74− 0.82 Han-297
ley, Mann-Whitney; 0.73−0.84 Maximum Variance). The the bias-corrected298
percentile bootstrap was regarded as a safe estimate as it did not require any299
assumption about the normality of the log-transformed AUC (Ahn and Yim,300
2009).301
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3. Results302
Results on volume and longitudinal feature (vˆ and Λ) are given after303
correction for age (de-correlation). Hippocampal volumes are given after304
correction for icv and in the MNI space with spatial sampling of 1×1×1 mm.305
3.1. Quality control306
Figure 3 shows the distribution of Revoi and Remask for all 460 subjects.307
There are three distinctive outliers which are excluded from subsequent anal-308
yses and whose inconsistent VOIs and tracings are shown aside (fig. 3a, b309
and c). Potential outliers - placed in the low value regions of the Revoi /310
Remask scatter plot - are visually screened to ensure that they are correctly311
classified as proper VOI and hippocampal tracings.312
One of the outliers (figure 3a) stems from a blind injection: a null image313
(white noise only) was placed in the analysis pipeline on purpose, in order314
to test the reliability of the whole analysis procedure. Another outlier (fig.315
3b) is due to incorrect brain spatial registration, causing the VOIs to be316
misplaced. The third one (fig. 3c) is due to the peculiar atrophy conditions,317
which has no related template in the HarP subject selection.318
3.2. Reproducibility319
The relative volume variation over baseline and repeat scan is given for320
the A, B, C and D implementations in percent units (%), mean and standard321
deviation: ∆A = −0.1 ± 3.5, ∆B = −0.1 ± 2.7, ∆C = 0.0 ± 0.1 and ∆D =322
0.1± 1.2. The absolute value of the standard deviation σv over the quantity323
vr − vb is: σAv = 156, σBv = 128, σCv = 5 and σDv = 68 (units in mm3).324
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3.3. Longitudinal trend325
Mean Λ values over cohorts and implementations are shown in table 2.326
Λ is significantly correlated to the baseline volume vˆ in implementations327
B, C and D. The Pearson correlation r is rA = 0.05 (p = 0.12), rB = 0.09328
(p = 0.01), rC = 0.41 (p < 10
−4) and rD = 0.37 (p < 10−4). In words,329
volume loss is higher (in absolute value, i.e. more negative numbers) in330
smaller structures.331
In terms of cohort discrimination, figure 4 shows the distribution and332
ROC curves of Λ for the right and left hippocampus separately, where it333
is apparent that the AUC steadily increases with the implementation com-334
plexity (from A → D). Comprehensive results on the AUC of vˆ and Λ are335
summarized in table 3.336
The average bilateral AUC remained significant (p < 10−4) after de-cor-337
relating baseline MMSE score (AUCA = 0.64, AUCB = 0.64, AUCC = 0.67338
AUCD = 0.70) and volume vˆ (AUCA = 0.66, AUCB = 0.66, AUCC = 0.63339
AUCD = 0.68).340
A derived alternative marker is the bilateral average of the relative annu-341
alized volume loss342
λ =
1
2
([Λ/vˆ]R + [Λ/vˆ]L)
expressed in %/year. Values (mean and standard deviation) are: λ =343
−1.6(0.55) for CTRL, λ = −2.2(1.0) for MCI-nc, λ = −3.2(1.2) for MCI-co344
and λ = −4.0(1.5) for AD (λ results are calculated on implementation D).345
In order to better specify the expected levels of relative annualized loss in346
potentially pathological subjects, the CTRL cohort is compared to an ‘AD-347
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like’ cohort consisting of subjects with AD together with subjects who sub-348
sequently developed AD (MCI-co). Using implementation D, we selected349
three cut-offs relevant for accuracy (acc), sensitivity (sens) and specificity350
(spec): λ = −2.19 (sens = 0.83, spec = 0.85, acc = 0.84, maximum accuracy351
criterion); λ = −1.28 (sens = 0.32, spec = 0.95, acc = 0.69); λ = −2.94352
(sens = 0.95, spec = 0.69, acc = 0.80). In this example the area under353
the ROC curve is AUC = 0.90 and a graphical representation of the two354
distributions is shown in figure 6.355
3.4. Combined markers356
The benefit of adding the trend information Λ to the average baseline357
volume vˆ is summarized in table 4 and graphically shown in figure 5. In each358
comparison, we marked whether the combined information fared significantly359
better than either factors. Considering a total of 3 (group comparisons) × 4360
(implementations) × 2 (laterality) = 24 tests, adding atrophy rate informa-361
tion to the baseline volume resulted in a significantly higher AUC (compared362
to that of the volume alone) in 14 tests.363
3.5. Sample size calculation364
To determine the power of the different implementations in detecting365
effects on hippocampal volume loss over time we estimated the sample size366
needed in a hypothetical treatment trial to measure a 25% slowing in Λ with367
α = 0.05 significance level and a power 1− β = 0.8.368
Using the formula369
n =
2σ2
(
z1−α/2 + z1−β
)2
δ2
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we chose δ = 0.25Λ where Λ = (ΛR+ΛL)/2 is the bilateral mean atrophy rate370
of the corresponding clinical group, σ their standard deviation and z values371
are z1−α/2 ' 1.96 and z1−β ' 0.84 respectively. For each patient group, the372
estimated sample sizes are displayed in table 5.373
4. Discussion374
In this study we evaluated the impact of using the longitudinal informa-375
tion deriving from serial MRI scans as an added value compared to ‘spot’376
baseline scans in patients with MCI or AD as compared to controls. The377
assumption was that atrophy rate with time could be a neurodegeneration378
marker independent of single atrophy measures. We showed that with a 2-y379
observation time this is true only if adequate post-processing is performed.380
On the other side, this means that 2-y repeated measures are useless when381
only a raw estimate of atrophy rate is performed ‘on the fly’, that is with a382
simple algorithm that does not embed the longitudinal information.383
We compared four possible algorithmic implementations of a volume384
marker in a longitudinal context, where the longitudinal information is taken385
into account with different degrees both in the pre-processing and post-386
processing steps. The first implementation (A) is considered for comparison387
only.388
The longitudinal information is translated into a simple measure Λ, which389
estimates the hippocampal volume drift (atrophy rate) in time; Λ is then used390
as a biomarker – alone and in combination with the average baseline volume391
vˆ – to assess its potential in discriminating among relevant clinical groups.392
All procedures are fully automated and implement an internal quality393
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check.394
Conceptually, the most similar work to this one is Wolz et al. (2010b) –395
where the longitudinal (i.e. time) information is embedded in the segmenta-396
tion workflow – and partially similar to McEvoy et al. (2011). We conclude397
that clinical insight into AD development of subject initially classified as398
MCI can be derived from quantitative measures processed simultaneously399
from multiple time points, and that these measures are more consistent than400
single-time point ones.401
To further reduce the atrophy rate uncertainties we could have used sev-402
eral more time points. This however would be an impractical protocol to403
implement outside clinical trials. Similarly, using two time points only (i.e.404
0 – 12m) would result in a larger error and a lower discrimination power405
(Wolz et al., 2010b).406
4.1. Quality control407
All procedures need a stable segmentation, which in turns depends on408
an accurate VOI placing. Segmentation accuracy with respect to the expert409
tracing is comparable to results in literature: the LEAP method (Wolz et al.,410
2010a) DICE index ' 0.85; adaboost, ada-SVM and Freesurfer (Morra et al.,411
2010) Precision ' 0.71 − 0.84, Recall ' 0.73 − 0.87; and in Lo¨tjo¨nen et al.412
(2011) DICE index ' 0.87.413
In this study the supplemental Revoi and Remask statistics are used as414
warning indicators of outliers as they compare a new VOI and related seg-415
mentation with the reference templates. If the templates do not sample the416
population extensively enough we may incur in extreme statistic values. In417
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the particular example shown in figure 3c, the VOI and its segmentation are418
not necessarily outliers per se; they are rather given a low rank due to the419
lack of similar templates. In facts, while Revoi captures structure other than420
the hippocampus, Remask refers to the segmentation alone, therefore its score421
is below the average.422
Other VOIs with significant and widespread atrophy dwell in the lower423
Re region for the same reason. Although these cases might bear little clinical424
significance, an extension of the template database would favourably impact425
the finding of true outliers.426
In the case of the purely noisy image (blank test) of figure 3a, Remask427
value still ranks among acceptable numbers while Revoi = 0; this is explained428
because GDIseg is based on atlas deformation and the transformation con-429
straints on the deformation field (such as the use of the demons algorithm430
and the smoothing parameters) are weakly affected by noise. In addition, the431
use of the intra-subject template and the averaged deformation field avoid432
the pitfalls of overestimating the changes in the atrophy rate (Thompson and433
Holland, 2011).434
4.2. Reproducibility435
The standard deviations in implementation A and B are rather conspicu-436
ous, that is in comparison to the volume change one would want to measure437
to discriminate among cohorts. Implementation C has a definitely lower438
mark, but this value is heavily biased by the re-normalization algorithm and439
doesn’t represent the true variability. Rather, it represents the error due to440
the threshold algorithm when applied to the averaged probability matrix aij.441
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The value of σvD though reflects the true difference between the baseline442
and the repeat scan, due to acquisition and processing noises. That is, in443
implementation D the probability atlas is fixed and there is no threshold step444
involved.445
The difference among implementations can also be appreciated with the446
normal probability plot for ∆ (supplemental figure S2), where deviation from447
the Gaussian distribution is rather marked for implementation A and B.448
Comparison to literature shows that results similar to the basic imple-449
mentations A and B are obtained in Maclaren et al. (2014) (with a total450
coefficient of variation of ' 3% on the hippocampus and using Freesurfer).451
452
4.3. Further methodological considerations453
In ADNI, subjects were scanned at different sites and with different MRI454
equipment. Besides, follow-up images could have been acquired with scanner455
models other than those used at baseline.456
The ADNI protocol goes a great length in assuring reproducibility among457
sites (Jack et al., 2008) and in addition, other studies showed that ADNI-like458
acquisitions and optimized analysis procedures (longitudinal processing in459
particular) are robust across sites, regardless of MRI system differences (see460
Jovicich et al. (2013) for a detailed analysis). There are though fewer studies461
combining intra-site and inter-site reproducibility – i.e. measuring the same462
participants on a variety of scanners – a condition which is relevant in the463
longitudinal paradigm. In their study, Reig et al. (2009) found that pooling464
of different sites data can add a significant error compared to intra-site vari-465
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ability, particularly in single-modality (T1) segmentations.466
We looked for subjects whose record showed the use of different MRI ma-467
chines. A survey of the CTRL cohort indicated that 42 out of 148 subjects468
(' 28%) were acquired with different scanner models at some follow-up visit469
(with respect to the MRI system used at baseline).470
The potential added variability was gauged with a direct comparison of the471
statistics using the non-parametric Kolmogorov-Smirnov test. The applica-472
tion to the sample of 106 CTRL (same scanner model across longitudinal473
measures but different cross-sectionally) and 42 CTRL subjects (different474
scanner model both in longitudinal measures and cross-sectionally) found no475
significant difference the Λ statistics, regardless of the implementation.476
Nonetheless, the use of different models in the longitudinal acquisition could477
show up in the linear fit residuals ξ (cfr. section 2.5.3). Indeed, testing478
the ξ distributions revealed a significant alteration in implementation A only479
(p < 0.001), which would suggest that the adoption of an intra-subject tem-480
plate (used in B, C and D) is sufficient to tame the inter-scanner repro-481
ducibility uncertainty. This finding agrees with Jovicich et al. (2013), where482
the introduction of longitudinal methods for volumes extraction provides a483
lower and more homogeneous reproducibility error across different scanners.484
Another point is the role of laterality. In this study we treated left and485
right hippocampi equally and separately to avoid any laterality bias in the486
results.487
The significance of a performance superiority of the left side was investigated488
by comparing the R and L AUC values with a t-test, regardless of the im-489
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plementation and cohort comparison, grouping only by feature (vˆ, Λ and490
(vˆ,Λ)). For instance, we tested the pooled set of AUC values for vˆR vs. vˆL491
taking all implementations (A-D) and cohort comparison shown in table 3492
(i.e. 12 values). The one-sample t-test was used to assess whether the mean493
of the difference AUCL-AUCR was compatible with zero.494
Results indicated that the R/L AUC difference was significant for vˆL > vˆR,495
(p < 0.001), moderately significant for ΛR > ΛL (p < 0.01) and not signifi-496
cant for (vˆ,Λ).497
The left hippocampus is usually smaller but AD prediction accuracy is less498
clearly tied to laterality, even though the left side seems to have a promi-499
nent role as discussed in Apostolova et al. (2010); Okonkwo et al. (2012).500
Our findings are in keeping with a meta-analysis pooling together data from501
several studies, showing that left hippocampal atrophy is usually more se-502
vere than the right one (Shi et al., 2009) and with Franko´ and Joly, Olivier503
(2013), where the volume loss in MCI and AD was significantly lower in the504
left hemisphere than in the right one.505
Speculation on the weight of laterality in AD prediction is outside the scope506
of this study. There are though important physiological findings linking the507
hippocampal laterality to potential mechanisms of neurodegeneration. In508
a series of elderly subjects with cognitive disturbance of increasing degrees509
of severity, a serum marker of oxidative stress was shown to directly corre-510
late with glucose metabolism of the left temporal lobe – including medial511
structures – but not of the right one (Picco et al., 2014). Also, the multi-512
functional mitochondrial enzyme 17β-hydroxysteroid dehydrogenase type 10,513
with high-affinity binding to amyloid-beta peptides, is more expressed in the514
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left than in the right hippocampus in patients with AD but not in patients515
with vascular dementia (Hovorkova et al., 2008).516
That said, the bilateral average usually offers a more robust estimator. In517
all implementations the standard deviation of the bilateral average (σRL ) is518
smaller than the mono-lateral counterparts. The relative measure 2σRL/(σR+519
σL) ranges in 92%− 96% for vˆ and 80%− 90% for Λ. This suggests that in-520
formed clinical use of atrophy rate should take into account both hippocampi,521
as we did in table 5 and in figure 6.522
4.4. Longitudinal trend and combined markers523
The annualized volume loss (atrophy rate) is in par with literature results524
(Barnes et al., 2009; Leung et al., 2010). Although other authors report differ-525
ent average values (Morra et al., 2009; Wolz et al., 2010b; Schuff et al., 2009),526
these values do not contrast with our findings due to the relatively large re-527
ported confidence intervals and possibly because of a potential difference in528
region definition, subjects selection and methodology, as also discussed in the529
Barnes et al. (2009) meta-analysis.530
In terms of discrimination power among groups, raw performance of vol-531
ume is comparable to Lo¨tjo¨nen et al. (2011) (CTRL / AD AUC= 0.89) and532
atrophy rate relates to those in Wolz et al. (2010b) where their method de-533
livers AUC= 0.88− 0.92 for CTRL vs. AD, AUC= 0.83− 0.86 for CTRL vs.534
MCI-co, and AUC= 0.71− 0.72 for MCI-nc vs MCI-co; numbers that agree535
with our integrated implementation D within the CL.536
To be clinically relevant, the use of repeated scans should improve on537
clinical group discrimination, and with respect to the baseline volume infor-538
27
mation.539
Results indicate that we can get substantially more insight only using540
implementation D, which comes at the expense of a partial segmentation, that541
is one that does not deliver a tracing around the anatomical structure. This542
can be understood if we consider that in hippocampal segmentation literature543
near-boundary voxels are those who carry the burden of uncertainty (in our544
study, the threshold applied to the probabilistic map is the major source of545
error). Giving up the tracing we (re-)discover that the probabilistic map546
does carry a significant information.547
If we compare the effect of the implementation on the longitudinal and548
baseline values while fixing the cohort comparison and feature (table 3),549
we find evidence that the use of an intra-subject template (impl. B) is550
not enough to make the difference. The decisive approach is the unified551
segmentation, in either variant (C and D).552
In clinical practice physicians are used to evaluate basal information on553
patient status, generate diagnostic hypothesis, plan treatment and then eval-554
uate response in the longitudinal assessment. Moreover the trend observed555
in longitudinal assessment adds value to confirm or put in discussion the556
original assumption. Theoretically, this longitudinal evaluation sounds more557
robust because intra-subject variance due to confounders is smaller than558
between-subject variance in cross-sectional data. Hence a longitudinal mea-559
sure of hippocampal atrophy could in principle be more informative than a560
spot measure whenever taken during the patient history.561
Translated into practice this would be similar to the advantage to have562
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– for instance – serial MMSE scores during patient follow-up as a measure563
of disease worsening, but based on a solid neurodegeneration marker. The564
pathological basis of our assumption is the ongoing neurodegeneration pro-565
cess in MTL structures during the early stages of the disease leading to566
progressive atrophy that can be precisely detected by adequate MRI mea-567
sures.568
As closing remark, the shorter the follow-up time, the higher the need for569
sophisticated analysis tools. Probably a longer (say 5 years) period would al-570
low simpler methods to detect significant changes, although that would void571
their need as the information would overlap with more direct and simpler572
approaches. Restricting the investigation to the time-varying hippocampal573
volume, it would be interesting to know whether this measure (on 2-y pe-574
riod and with 1.5T images) has reached an upper limit in terms of added575
value. This could perhaps be challenged by a longitudinal extension to the576
harmonized hippocampal segmentation study.577
4.5. Study limitations578
We considered 1.5T images only. Surely 3T images could provide better579
contrast and potentially a more reliable segmentation (Chow et al., 2015).580
In practice though, this and other studies (Lo¨tjo¨nen et al., 2011; Macdon-581
ald et al., 2014) show that the advantages of 3T images do not necessarily582
translate into a decidedly smaller variance in test/re-test conditions. Besides,583
clinical practice and still many trials must cope with 1.5T scanners. These584
reasons would qualify the present study as delivering a lower bound, on which585
the use of better scanners and acquisition protocols should only improve.586
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In addition, the use of a preliminary release (100 out of the now available587
135 labels) of the cross-sectional gold-standard tracings – without a longitu-588
dinal benchmark – did not provide a hint to the longitudinal performance589
achievable by a given algorithm. Perhaps a further evolution of the hip-590
pocampal protocol study could help in assessing new methods cross-sectional591
as well as longitudinal performance.592
Another point arises from the use of the hippocampal volume and its593
derivative marker Λ, as they do not necessarily implement the most sensi-594
tive measure of early AD. For instance, more sophisticated approaches based595
on local geometry measures could be more informative (see Franko´ and Joly,596
Olivier (2013)). Still, the volume is a rather straightforward and robust mea-597
sure which more easily serves the purpose of confrontation among algorithms598
and studies. In addition, the hippocampal volume is now a widely accepted599
marker among clinicians.600
We must also consider that the cohorts in this study consist of rather601
elderly subjects. It is conceivable that younger subjects (i.e. 40-60 y) exhibit602
smaller longitudinal variability than their elderly counterparts. In this case,603
the distinction between healthy controls and a population at risk could be604
made more substantial and a longitudinal marker would be instrumental.605
Further studies are needed on relatively young subjects.606
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Table 2: Mean Λ values.
CTRL MCI-nc MCI-co AD
R
A -75.90 (84.62) -80.04 (89.81) -135.80 (93.15) -135.54 (90.59)
B -72.60 (67.46) -96.99 (69.46) -129.63 (87.30) -140.09 (83.22)
C -69.32 (47.40) -98.39 (66.19) -131.29 (67.50) -154.58 (73.46)
D -76.27 (23.40) -91.96 (37.74) -124.41 (45.34) -143.10 (54.22)
L
A -61.83 (79.76) -73.76 (96.06) -111.40 (88.74) -108.91 (85.86)
B -56.48 (53.35) -61.14 (86.43) -95.81 (72.96) -101.47 (91.23)
C -59.82 (43.71) -72.01 (54.72) -113.99 (59.09) -133.65 (60.39)
D -63.34 (25.19) -77.70 (40.32) -108.19 (44.21) -122.80 (47.32)
Annualized volume change (Λ) in mm3/year (mean and standard deviation).
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Table 3: Performance (AUC).
Feat. Impl. CTRL/MCI-nc CTRL/MCI-co CTRL/AD
vˆR
A 0.71 (0.65 – 0.74) 0.79 (0.75 – 0.83) 0.86 (0.81 – 0.89)
B 0.71 (0.65 – 0.75) 0.79 (0.75 – 0.83) 0.85 (0.81 – 0.88)
C 0.71 (0.66 – 0.77) 0.82 (0.77 – 0.85) 0.87 (0.83 – 0.90)
D 0.71 (0.66 – 0.76) 0.82 (0.78 – 0.85) 0.87 (0.83 – 0.90)
vˆL
A 0.72 (0.67 – 0.78) 0.82 (0.79 – 0.86) 0.88 (0.85 – 0.91)
B 0.72 (0.68 – 0.77) 0.83 (0.78 – 0.86) 0.88 (0.83 – 0.91)
C 0.73 (0.68 – 0.78) 0.84 (0.80 – 0.87) 0.89 (0.85 – 0.92)
D 0.73 (0.67 – 0.77) 0.84 (0.80 – 0.87) 0.89 (0.85 – 0.92)
ΛR
A 0.52 (0.46 – 0.57) 0.69 (0.64 – 0.73)∗ 0.69 (0.63 – 0.73)∗
B 0.60 (0.55 – 0.66) 0.71 (0.66 – 0.75)∗ 0.73 (0.68 – 0.78)∗
C 0.64 (0.58 – 0.69) 0.78 (0.73 – 0.82) 0.84 (0.80 – 0.88)∗
D 0.63 (0.57 – 0.69) 0.83 (0.79 – 0.87) 0.89 (0.85 – 0.92)
ΛL
A 0.55 (0.49 – 0.60)∗ 0.68 (0.63 – 0.73)∗ 0.66 (0.60 – 0.71)∗
B 0.54 (0.47 – 0.59)∗ 0.68 (0.63 – 0.73)∗ 0.67 (0.62 – 0.73)∗
C 0.56 (0.50 – 0.61) 0.77 (0.72 – 0.80) 0.84 (0.79 – 0.87)
D 0.60 (0.55 – 0.67) 0.82 (0.77 – 0.86) 0.88 (0.84 – 0.91)
(vˆ,Λ)R
A 0.68 (0.62 – 0.74) 0.83 (0.79 – 0.87)∗ 0.89 (0.85 – 0.91)
B 0.71 (0.66 – 0.77) 0.83 (0.78 – 0.86)∗ 0.89 (0.85 – 0.91)
C 0.71 (0.66 – 0.76) 0.85 (0.81 – 0.88) 0.90 (0.86 – 0.93)
D 0.70 (0.64 – 0.76) 0.87 (0.84 – 0.90) 0.92 (0.88 – 0.94)
(vˆ,Λ)L
A 0.72 (0.66 – 0.76) 0.85 (0.81 – 0.88) 0.89 (0.86 – 0.92)∗
B 0.69 (0.64 – 0.75) 0.84 (0.81 – 0.88) 0.88 (0.84 – 0.91)∗
C 0.70 (0.65 – 0.76) 0.85 (0.82 – 0.88) 0.91 (0.87 – 0.93)
D 0.71 (0.66 – 0.75) 0.88 (0.84 – 0.90) 0.93 (0.90 – 0.95)
Area under the ROC curve. Numbers within parentheses are the 95% con-
fidence interval. The ‘∗’ indicates significant difference (p < 0.001) between
implementation D and A, B or C for each respective feature and cohort
comparison.
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Table 4: Performance comparison.
Impl.
CTRL / MCI-co CTRL / AD MCI-nc / MCI-co
vˆ Λ (vˆ,Λ) vˆ Λ (vˆ,Λ) vˆ Λ (vˆ,Λ)
R
A 0.79 0.69 0.83 ∗ † 0.86 0.69 0.89 † 0.58 ‡ 0.67 0.66 ∗
B 0.79 0.71 0.83 ∗ † 0.85 0.73 0.88 † 0.58 ‡ 0.63 0.64
C 0.82 0.78 0.85 † 0.87 0.84 0.90 † 0.62 0.64 0.66
D 0.82 0.83 0.87 ∗ † 0.87 0.89 0.92 ∗ 0.62 0.71 0.72 ∗
L
A 0.82 0.68 0.85 † 0.88 0.66 0.90 † 0.61 0.62 0.66
B 0.83 0.68 0.84 † 0.88 0.67 0.88 † 0.61 0.63 0.67 ∗
C 0.84 0.77 0.85 † 0.89 0.84 0.91 ∗ † 0.64 0.71 0.71 ∗
D 0.84 0.82 0.88 ∗ † 0.89 0.88 0.93 ∗ † 0.64 0.72 0.73 ∗
Performance (AUC) comparison for vˆ, Λ and the combined marker. Signif-
icant changes (p < 0.001) are marked as ‘∗’ for the test (vˆ,Λ) vs. vˆ; ‘†’ for
the test (vˆ,Λ) vs. Λ. ‘‡’ shows the AUC which are not significantly different
from 0.5.
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Table 5: Sample size calculation.
Impl. CTRL MCI-nc MCI-co AD
A 267 (210 – 357) 268 (211 – 359) 88 (69 – 117) 85 (67 – 114)
B 153 (120 – 204) 169 (133 – 227) 77 (61 – 104) 101 (79 – 135)
C 91 (72 – 122) 103 (81 – 138) 58 (46 – 78) 42 (33 – 57)
D 25 (20 – 33) 45 (35 – 60) 33 (26 – 44) 33 (26 – 44)
Estimated sample sizes for both arms that would be needed to detect a 25%
reduction in atrophy in all clinical cohorts and implementations. Numbers
are given at fixed α = 0.05 and for power 1− β = 0.8 (0.7− 0.9).
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Figure 1: Positioning and content of a sample hippocampal VOI.
48
Figure 2: Schematic flowchart of the four implementations. The four MRI drawings
represents the baseline, repeat, month 12 and month 24 scans. In implementation A
(section 2.4.1) all four images follow a separate preprocessing and segmentation path. In
implementation B (section 2.4.2) an intermediate image H is generated and preprocessing
is performed on it; parameters are then mapped back onto the original images to extract
the VOIs. In implementation C (section 2.4.3) the VOIs extracted with the B procedure
are segmented together with atlas re-normalization. Implementation D (section 2.4.4)
avoids the shape segmentation and delivers an equivalent volume only.
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Figure 3: Left: reliability scatter plot over VOIs (x-axis) and hippocampal masks (y-axis).
Each circle represents a subject. Lower scores are an indication of either improper image
processing or biased template sampling. a,b and c are outliers. The dotted outline shows
the subject who underwent visual inspection. Right: coronal and sagittal view of the three
outlier VOIs. The red outline shows the GDIseg hippocampal tracing.
50
RL
Figure 4: Distribution of Λ for the right hippocampus (top) and left hippocampus (bot-
tom) on Controls (CTRL), Mild Cognitive Impairment non-converters / converters (MCI-
nc/MCI-co) and Alzheimer’s Disease (AD) subjects. The median and its 95% conf. interval
are marked with a black dot and triangles on each bar. The related ROC curves and area
under the curves (AUC) are shown on the right plots
51
RL
Figure 5: Baseline volume vˆ and combined markers (vˆ,Λ) performance comparison and
implementation dependence. Area under the ROC curve (AUC) is shown for CTRL vs.
MCI-co (full line) and CTRL vs. AD subjects (dotted line).
52
Figure 6: Boxplot of the bilateral average of the relative annualized loss lambda on the
CTRL and the ‘AD-like’ (AD + MCI-co) cohorts. Vertical lines shows three possible cut-
off values: maximum accuracy (solid line), 95% sensitivity and 95% specificity (dashed
lines). The median and its 95% conf. interval are marked with a dot and triangles on each
bar.
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Appendix A. Segmentation algorithm859
The GDIseg algorithm is based on a set of manually traced segmentations860
by expert and certified readers from the HarP project. At the time of this861
writing, 100 manual tracings were made available (58 1.5T and 42 3T)862
Reference HarP images were processed as in section 2.2. In addition we863
extracted the VOIs from the manually segmented masks, using the same864
coordinates found for extracting the VOIs from the MRI.865
We refer to the set of VOIs from the HarP MR images as Template866
Boxes (TBs) and the set of the corresponding segmented masks as Template867
Masks (TMs), both naturally coming with the right (R) and left (L) label.868
A pictorial overview of the segmentation process is shown in supplemental869
figure S1.870
For each new segmentation, the MRI goes through the pre-process steps871
up to the extraction of both hippocampal VOIs (target VOIs). Subsequently,872
each TB is mapped onto the target VOI with a deformable registration873
transform, implemented in ITK with the “Diffeomorphic Demons” algorithm874
(Thirion (1998) and http://hdl.handle.net/1926/510). The resulting de-875
formation field - one for each TB - is applied to the corrensponding TM .876
At this point of the procedure, we have 100 deformed TBs (δTBs) and877
TMs (δTMs) to map the target VOI (L and R VOIs are run separately).878
Naturally, the more similar the original TB is to the target VOI, the lesser879
deformation it experiences and the more it ideally maps onto the target VOI.880
A probabilistic atlas A is generated by weighted average of all deformed881
TMs, followed by a normalization. All VOIs, TBs, TMs and their deformed882
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counterparts (δTBs, δTMs) have the same dimensions and number of voxels,883
so that we can write884
A =
Nt∑
i=1
wi δTMi
where Nt is the number of templates.885
In order to find the weights wi, the TBs are ranked according to the Pear-886
son correlation coefficient r with the target VOI. The correlation coefficient887
is not computed over the whole volume of the VOI, but on a subset of voxels888
corresponding to the volume surrounding the TM . The detailed procedure889
consists in three steps: a) dilation of the the binary TM (distance of 3mm),890
b) mapping of the the dilated TM onto both the target VOI and the TB891
(voxel selection), c) computation of the correlation coefficient r between the892
intensities of both volumes over the selected voxels.893
This procedure is applied to each TB using the related TM as initial894
mask to dilate. The dilation step is instrumental to capture the intensity895
gradient of the hippocampal borders, thereby ranking TBs according to their896
similarity to the target VOI more effectively. If we had used the whole VOI897
volume, the correlation coefficient would have been swayed by intensities898
coming from tissues unrelated to the hippocampus.899
The correlation rank is used to compute the weights in the TMs average,900
under the hypothesis that it contains information on the “true segmentation”.901
In this sense, correlation values are used as proxies for the segmentation902
similarity.903
Since we do not know the target VOI true segmentation, we use a sur-904
rogate target δTB∗ - that is the deformed TB with the best rank - in place905
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of the target VOI, with the benefit that the true segmentation δTM∗ is now906
available.907
Weights are thought to be a simple exponential functions of the correla-908
tion coefficient, they are computed by minimizing the distance m over the909
free parameter s (s ≥ 0)910
m =
∑
all voxels
δTM∗ −
N∑
i=1,i 6=i∗
wi δTMi
N∑
i=1,i 6=i∗
wi

2
911
wi =
(
ri
maxi(ri)
)s
where N is the number of templates, i∗ is the index of the surrogate tar-912
get δTB∗ and ri are the correlation coefficients now computed between the913
surrogate target δTB∗ and the TBs.914
Once we find the optimal value of the parameter, we have a relationship915
between the correlation coefficients and the weights, which is then used to916
construct the probabilistic atlas.917
The weight function optimizes the atlas generation by selecting TBs with918
a non-linear proportionality relationship. This step is necessary to the algo-919
rithm accuracy as a simple average (equal weights, s = 0) of the deformed920
masks typically results in smeared out atlas, not always able to capture the921
subtle anatomical and intensity differences in the target VOI.922
The optimization is carried out for each target VOI, so that parameter923
values are adapted to the target. We found that the weight function wi is924
usually rather steep (s 1), that is only a small number of δTMs contribute925
56
to the probabilistic atlas.926
The last step takes the probabilistic atlas A and applies a threshold t on its927
intensity values to convert it to a binary mask: A(t) = {xi such as A(xi) ≥ t}.928
The optimal threshold is defined as929
t∗ = max
t
{ 1
n
∑
xi∈∂A(t)
[∇A(xi)]2}
where ∇A is the 3D-gradient of the atlas A, xi is the i− th voxel, ∂A(t) is930
the boundary of the thresholded atlas, n is the number of voxels xi belonging931
to ∂A(t). That is, the optimal threhsold is the intensity value t
∗ that max-932
imises the overlap of the thresholded atlas boundary onto the atlas squared933
gradient.934
We have found that the maximization over the gradient gives superior935
performance - in terms of DICE index - compared to the simple intensity936
rule937
t∗ =
1
2
max
xi
A(xi)
The thresholded atlas naturally yields the hippocampal volume v which938
is used as base measure in this study.939
The performance of the GDIseg procedure was tested on the same HarP940
dataset using a 20-fold cross-validation method (kfcv) and it was evaluated941
by three standard indexes: DICE (Dc, or F1-score), Recall (Rc, or sensitiv-942
ity) and Precision (Pr, or positive predictive value). Results are shown in943
supplemental table S2.944
Since the 100 images from the HarP database consisted in 58 1.5T and 42945
57
3.0T MRI, we show the performance by field strength, demonstrating that946
the segmentation algorithm is not affected by the B-field intensity.947
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Table S2: Cross-validation performance.
Metric 1.5T+3.0T 1.5T 3.0T
Dc 0.85 (0.82 – 0.88) 0.85 (0.83 – 0.87) 0.86 (0.81 – 0.89)
Pr 0.87 (0.80 – 0.92) 0.87 (0.80 – 0.91) 0.87 (0.76 – 0.93)
Rc 0.85 (0.79 – 0.90) 0.84 (0.79 – 0.89) 0.85 (0.76 – 0.91)
Dice (Dc), Recall (Rc) and Precision (Pr) measured with a k-fold cross-
validation method on the 100 HarP manual tracings. Statistics are calculated
on the right and left hippocampi together, for a total of 200 (1.5T+3.0T),
116 (1.5T) and 94 (3.0T) segmentations. Within parentheses are the 5% and
95% confidence level values.
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Figure S1: Segmentation algorithm flowchart. TB set: reference VOIs (template boxes);
TM set: manually traced reference segmentations (template masks); δTB, δTM: reference
boxes and labels after the deformable registration; δTB*, δTM*: surrogate box and mask,
i.e. the transformed template box and mask which has the highest correlation rank with
the VOI.
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Figure S2: Normal probability plot of the reproducibility error ∆. Dotted lines show the
best gaussian distribution fitted over the experimental data. Deviation from the straight
line indicates non-gaussian behaviour.
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